Which antiseizure medication is considered narrow-spectrum and is used specifically for absence seizures by blocking T-type calcium channels?
Choose an answer, then check it.
Clinical Pharmacology · Neurologic Medications
Antiseizure Medications
On this page 6 sections
In 30 seconds
Antiseizure medications (ASMs) calm hyperexcitable neurons by blocking sodium or calcium channels, boosting GABA inhibition, or dampening glutamate excitation, so an electrical storm cannot spread across the brain. Choosing the right drug means matching mechanism to seizure type, starting one drug at a low dose and titrating slowly, and never stopping abruptly, since sudden withdrawal can trigger status epilepticus. Several agents carry signature toxicities nurses must recognize early: phenytoin's gum overgrowth and unpredictable levels, valproate's liver and fetal risk, carbamazepine's low sodium and induced enzymes, and a class-wide caution about mood and suicidality. Status epilepticus itself is managed with a benzodiazepine first, then a longer-acting agent to prevent recurrence.
The college version
Matching Mechanism to Seizure Type
Seizures arise from excessive, synchronized neuronal firing, and ASMs interrupt that process at different points. Broad-spectrum agents (valproate, lamotrigine, levetiracetam, topiramate) work across focal and generalized seizures, while narrow-spectrum agents target specific circuits, such as ethosuximide for absence seizures only. Choosing wrong can worsen control or even aggravate certain generalized seizure types. Clinicians generally begin with monotherapy at the lowest effective dose and titrate slowly, which limits side effects, allows the body to adjust, and makes it easier to identify which drug caused a reaction if one appears. Add-on therapy is reserved for seizures that persist despite an adequate trial. Because tolerance to inhibitory circuits develops with chronic use, stopping an ASM abruptly removes that inhibition suddenly and can precipitate rebound seizures or status epilepticus; tapering is required even when switching agents.
Sodium Channel Blockers
Phenytoin, fosphenytoin (its water-soluble prodrug for parenteral use), carbamazepine, oxcarbazepine, and lacosamide stabilize the inactivated state of voltage-gated sodium channels, slowing repetitive neuronal firing. Phenytoin is notable for nonlinear, zero-order kinetics at therapeutic doses: past a saturation point, small dose increases produce disproportionately large rises in blood level, so levels must be monitored closely. It is highly protein-bound, meaning conditions that lower albumin (or displace it from binding sites) raise the free, active fraction without necessarily raising the total measured level. Classic toxicities include gingival hyperplasia, hirsutism, nystagmus, and ataxia; IV administration must be given cautiously and diluted appropriately because extravasation can cause purple glove syndrome, a painful discoloration and swelling of the injected limb. Fosphenytoin avoids some of this local tissue risk. Carbamazepine and oxcarbazepine share sodium-channel action; carbamazepine is a potent inducer of hepatic enzymes (lowering levels of many co-administered drugs, including hormonal contraceptives) and can cause hyponatremia through inappropriate antidiuretic hormone-like effects. Carbamazepine also carries a genetic risk: patients with the HLA-B*1502 allele, more common in certain Asian ancestries, have markedly elevated risk of severe skin reactions, so screening is recommended before starting therapy in at-risk populations. Lamotrigine, while also affecting sodium channels, is best known for a dose- and titration-dependent rash risk that can progress to a severe hypersensitivity reaction, which is why its dose is increased very gradually. Lacosamide selectively enhances slow inactivation of sodium channels and is used both orally and intravenously for focal seizures.
Calcium Channel Modulators
Ethosuximide blocks T-type calcium channels in thalamic neurons that generate the rhythmic spike-and-wave discharges of absence seizures, making it a narrow-spectrum, first-line choice for that seizure type alone; it does not help generalized tonic-clonic or focal seizures. The gabapentinoids (gabapentin and pregabalin) bind the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release; they are used as adjunctive therapy for focal seizures and are also widely used for neuropathic pain.
GABA Enhancers
This group increases inhibitory tone. Benzodiazepines enhance GABA-A receptor chloride conductance and are the first-line agents for acute seizure termination, including status epilepticus, though tolerance limits their use for long-term maintenance. Phenobarbital, an older barbiturate, prolongs GABA-A channel opening and remains useful, particularly in neonatal seizures and resistant cases, but requires therapeutic monitoring and carries sedation and dependence risk. Valproate broadens GABA availability among other mechanisms and is a broad-spectrum agent effective across seizure types, but it is strongly associated with hepatotoxicity (requiring monitoring of liver function) and is a major human teratogen, causing neural tube defects and other malformations, so it is avoided when possible in people who could become pregnant. Vigabatrin irreversibly inhibits GABA transaminase, the enzyme that degrades GABA, boosting inhibitory tone but carrying a risk of permanent visual field loss, requiring routine vision monitoring. Tiagabine blocks GABA reuptake into neurons and glia, prolonging its synaptic action.
Glutamate Blockers and the SV2A Ligand
Topiramate has multiple actions, including dampening glutamate signaling, and is broad-spectrum, but it is well known for cognitive slowing (word-finding difficulty, reduced concentration), an increased risk of kidney stones, and weight loss, which can be a therapeutic advantage in some patients but a concern in others. Perampanel directly antagonizes AMPA-type glutamate receptors, reducing excitatory transmission. Levetiracetam binds the synaptic vesicle protein SV2A, altering neurotransmitter release in a mechanism distinct from other classes; it is broad-spectrum, requires minimal drug interaction monitoring, and is popular for its favorable kinetic profile, but it is notable for behavioral and mood effects, including irritability, agitation, and rarely depression or psychosis.
Shared Safety Themes
The FDA has placed a class-wide warning across ASMs regarding increased risk of suicidal thoughts and behavior, so mood changes should be monitored during initiation and dose changes for any agent in this class. Enzyme-inducing agents (carbamazepine, phenytoin, and to a lesser extent oxcarbazepine and topiramate at higher doses) accelerate metabolism of hormonal contraceptives, reducing their effectiveness and requiring alternative or additional contraception. Because several ASMs (especially valproate and enzyme inducers) increase the risk of neural tube defects, folic acid supplementation is recommended for anyone of childbearing potential who takes an ASM. Older, narrow therapeutic index agents (phenytoin, carbamazepine, valproate, phenobarbital) require therapeutic drug monitoring to balance efficacy against toxicity, while newer agents like levetiracetam and lamotrigine generally do not require routine level checks.
Status Epilepticus
Status epilepticus is a prolonged or repeated seizure without full recovery between episodes, and it is a medical emergency because sustained neuronal firing causes excitotoxic injury. Management follows a stepwise algorithm: a benzodiazepine is given first because it works quickly to restore GABA-mediated inhibition, followed by a longer-acting agent (such as phenytoin, fosphenytoin, valproate, or levetiracetam) to prevent seizure recurrence once the acute event is controlled.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine your brain is a big room full of light switches, and normally only a few flip on and off in a nice, calm rhythm. A seizure is like every switch in the room flipping on at once in a chaotic wave. Antiseizure medicines are like different kinds of switch-guards: some jam the switches so they can't flip so fast (sodium blockers), some slow down a special "starter" switch in one part of the room (calcium blockers), some turn up a "calm down" whisper that tells switches to stay off (GABA enhancers), and some turn down a "hype up" shout that gets switches excited (glutamate blockers). Doctors pick the right guard for the right kind of switch problem, and they add it slowly, like turning a dimmer instead of flipping a breaker, because yanking the guard away suddenly can make the chaos come back worse than before. Some guards have weird side effects too, like one that makes gums puffy or one that's risky for a growing baby, so doctors watch closely and check blood levels for the trickiest ones. If a seizure won't stop, doctors first give a fast-acting calm-down medicine, then a longer-lasting one to keep the switches calm afterward.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient with epilepsy who has been seizure-free for two years decides to stop her lamotrigine abruptly because she feels fine. What is the key risk of this action, and why does it happen?
Show answer
Stopping abruptly can trigger rebound seizures or status epilepticus.
The brain has adjusted to having extra "calm down" help from the medicine, so if that help disappears suddenly, the excitable circuits can fire out of control, sometimes worse than before treatment started. That's why ASMs are always tapered slowly instead of stopped all at once.
A nurse is preparing to administer a benzodiazepine and a second, longer-acting antiseizure drug to a patient in status epilepticus. Explain the rationale for using two different agents in this sequence rather than just one.
Show answer
The benzodiazepine acts fast to stop the seizure right now, while the second drug keeps it from coming back.
Benzodiazepines quickly boost GABA inhibition and are the fastest way to break an ongoing seizure, but their effect wears off relatively soon. A longer-acting agent is added afterward to maintain seizure control and prevent the patient from slipping back into status epilepticus once the benzodiazepine's effect fades.
Quick check
3 questions here. Answers stay hidden until you check.
A patient on phenytoin has a subtherapeutic total level, but she also has low serum albumin. Which concept best explains why her free (active) phenytoin fraction could still be adequate despite a "low" total level?
Choose an answer, then check it.
Which combination of drug and its hallmark toxicity is correctly matched?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.